Global Genome Editing Enzymes Supply, Demand and Key Producers, 2026-2032
The global Genome Editing Enzymes market size is expected to reach $ 655 million by 2032, rising at a market growth of 5.0% CAGR during the forecast period (2026-2032).
Genome editing enzymes are specialized proteins that can recognize, cut, or modify specific DNA sequences within an organism’s genome, enabling precise genetic alterations. The most well-known are nucleases such as CRISPR-Cas systems, TALENs (Transcription Activator-Like Effector Nucleases), and ZFNs (Zinc Finger Nucleases), which create targeted double-strand breaks that cells repair, allowing insertion, deletion, or correction of genes. Other enzymes, like base editors and prime editors, can make more subtle nucleotide-level changes without cutting both DNA strands. These tools are widely applied in biomedical research, agriculture, and potential therapies, offering unprecedented control over gene function for purposes ranging from disease modeling to crop improvement. Published list prices show wide dispersion: research-grade Cas proteins from ~€81 for 70 pmol Cas12a to ~€289 for 2000 pmol, ~$879–$1,022 for 500 µg Cas9.
Genome Editing Enzymes constitute a more narrowly defined upstream product market than the broader CRISPR, genome-editing, or gene-therapy industries. The core commercial objects are independently purchasable purified recombinant nucleases and engineered editor proteins, rather than guide RNAs, plasmids, messenger RNA, viral vectors, edited cell lines, technology licenses, or therapeutic products. This distinction substantially reduces the addressable market and excludes many highly visible therapeutic developers from the formal supplier list. Cas9 remains the largest product family by both revenue and standardized volume, while Cas12a expands accessible target regions and engineered high-fidelity variants address off-target concerns. Catalytically inactive dCas9, base-editor proteins, and emerging prime-editor proteins extend the market beyond conventional double-strand cleavage toward transcriptional regulation and precise sequence conversion. The industry is therefore best described as a growth market with two different maturity profiles: standard research-use SpCas9 is becoming a relatively mature and increasingly price-competitive reagent, whereas GMP-grade nucleases and advanced editor proteins remain in an earlier, higher-growth stage.
From a supply perspective, North America, China, and Western Europe account for most verified commercial manufacturing and supply capabilities. North American companies benefit from broad portfolios, established intellectual-property positions, global distribution, and integrated research-to-clinical manufacturing infrastructure. Danaher combines IDT’s Cas-enzyme and guide-RNA portfolio with Aldevron’s research-grade and cGMP nuclease manufacturing capabilities, while Thermo Fisher, Merck KGaA, New England Biolabs, and Synthego provide substantial coverage of standard, high-fidelity, and specialized Cas products. Europe has fewer suppliers but includes differentiated clinical-grade capacity, particularly Biomay’s FDA-inspected Cas9 manufacturing operation. China has developed a larger and more diverse domestic supplier base, including Vazyme, Novoprotein, KACTUS, Yeasen, Tolo Biotech, ACROBiosystems, and Beyotime. Chinese suppliers are moving beyond conventional research-grade Cas9 toward Cas12a, engineered variants, and GMP-grade materials, although most still have less extensive global clinical-manufacturing histories and regulatory documentation than the leading Western suppliers.
This report is a detailed and comprehensive analysis of the world market for Genome Editing Enzymes and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Genome Editing Enzymes that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Genome Editing Enzymes market
2. What is the demand of the global Genome Editing Enzymes market?
3. What is the year over year growth of the global Genome Editing Enzymes market?
4. What is the production and production value of the global Genome Editing Enzymes market?
5. Who are the key producers in the global Genome Editing Enzymes market?
6. What are the growth factors driving the market demand?
Genome editing enzymes are specialized proteins that can recognize, cut, or modify specific DNA sequences within an organism’s genome, enabling precise genetic alterations. The most well-known are nucleases such as CRISPR-Cas systems, TALENs (Transcription Activator-Like Effector Nucleases), and ZFNs (Zinc Finger Nucleases), which create targeted double-strand breaks that cells repair, allowing insertion, deletion, or correction of genes. Other enzymes, like base editors and prime editors, can make more subtle nucleotide-level changes without cutting both DNA strands. These tools are widely applied in biomedical research, agriculture, and potential therapies, offering unprecedented control over gene function for purposes ranging from disease modeling to crop improvement. Published list prices show wide dispersion: research-grade Cas proteins from ~€81 for 70 pmol Cas12a to ~€289 for 2000 pmol, ~$879–$1,022 for 500 µg Cas9.
Genome Editing Enzymes constitute a more narrowly defined upstream product market than the broader CRISPR, genome-editing, or gene-therapy industries. The core commercial objects are independently purchasable purified recombinant nucleases and engineered editor proteins, rather than guide RNAs, plasmids, messenger RNA, viral vectors, edited cell lines, technology licenses, or therapeutic products. This distinction substantially reduces the addressable market and excludes many highly visible therapeutic developers from the formal supplier list. Cas9 remains the largest product family by both revenue and standardized volume, while Cas12a expands accessible target regions and engineered high-fidelity variants address off-target concerns. Catalytically inactive dCas9, base-editor proteins, and emerging prime-editor proteins extend the market beyond conventional double-strand cleavage toward transcriptional regulation and precise sequence conversion. The industry is therefore best described as a growth market with two different maturity profiles: standard research-use SpCas9 is becoming a relatively mature and increasingly price-competitive reagent, whereas GMP-grade nucleases and advanced editor proteins remain in an earlier, higher-growth stage.
From a supply perspective, North America, China, and Western Europe account for most verified commercial manufacturing and supply capabilities. North American companies benefit from broad portfolios, established intellectual-property positions, global distribution, and integrated research-to-clinical manufacturing infrastructure. Danaher combines IDT’s Cas-enzyme and guide-RNA portfolio with Aldevron’s research-grade and cGMP nuclease manufacturing capabilities, while Thermo Fisher, Merck KGaA, New England Biolabs, and Synthego provide substantial coverage of standard, high-fidelity, and specialized Cas products. Europe has fewer suppliers but includes differentiated clinical-grade capacity, particularly Biomay’s FDA-inspected Cas9 manufacturing operation. China has developed a larger and more diverse domestic supplier base, including Vazyme, Novoprotein, KACTUS, Yeasen, Tolo Biotech, ACROBiosystems, and Beyotime. Chinese suppliers are moving beyond conventional research-grade Cas9 toward Cas12a, engineered variants, and GMP-grade materials, although most still have less extensive global clinical-manufacturing histories and regulatory documentation than the leading Western suppliers.
Report Scope
This report studies the global Genome Editing Enzymes production, demand, key manufacturers, and key regions.This report is a detailed and comprehensive analysis of the world market for Genome Editing Enzymes and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Genome Editing Enzymes that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Genome Editing Enzymes total production and demand, 2021-2032, (µg)
- Global Genome Editing Enzymes total production value, 2021-2032, (USD Million)
- Global Genome Editing Enzymes production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (µg), (based on production site)
- Global Genome Editing Enzymes consumption by region & country, CAGR, 2021-2032 & (µg)
- U.S. VS China: Genome Editing Enzymes domestic production, consumption, key domestic manufacturers and share
- Global Genome Editing Enzymes production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (µg)
- Global Genome Editing Enzymes production by Type, production, value, CAGR, 2021-2032, (USD Million) & (µg)
- Global Genome Editing Enzymes production by Application, production, value, CAGR, 2021-2032, (USD Million) & (µg)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Genome Editing Enzymes market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (µg) and average price (US$/µg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Genome Editing Enzymes Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Global Genome Editing Enzymes Market, Segmentation by Type:
- CRISPR-Associated (Cas) Enzymes
- Base Editing Enzymes
- Prime Editors
- Others
Global Genome Editing Enzymes Market, Segmentation by State:
- Wild-Type Cleaving Nucleases
- PAM-Engineered Nucleases
Global Genome Editing Enzymes Market, Segmentation by Quality:
- Research Use Grade
- Process-Development Grade
Global Genome Editing Enzymes Market, Segmentation by Application:
- Basic Research
- Biomedicine
- Agriculture
- Others
Companies Profiled:
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Merck
- New England Biolabs, Inc.
- Synthego Corporation
- Takara Bio Inc.
- Revvity, Inc.
- ACROBiosystems Co., Ltd.
- Nanjing Vazyme Biotech Co., Ltd.
- Suzhou Novoprotein Scientific Co., Ltd.
- KACTUS Biotechnology
- Biomay AG
- Yeasen Biotechnology
- Tolo Biotech
- BIONEER Corporation
- Agilent Technologies, Inc.
- OriGene Technologies, Inc.
- Beyotime Biotechnology
- Creative Enzymes
- OZ Biosciences SAS
- Creative Biogene
- ProteoGenix SAS
Key Questions Answered:
1. How big is the global Genome Editing Enzymes market?2. What is the demand of the global Genome Editing Enzymes market?
3. What is the year over year growth of the global Genome Editing Enzymes market?
4. What is the production and production value of the global Genome Editing Enzymes market?
5. Who are the key producers in the global Genome Editing Enzymes market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Genome Editing Enzymes Introduction
1.2 World Genome Editing Enzymes Supply & Forecast
1.2.1 World Genome Editing Enzymes Production Value (2021 & 2025 & 2032)
1.2.2 World Genome Editing Enzymes Production (2021-2032)
1.2.3 World Genome Editing Enzymes Pricing Trends (2021-2032)
1.3 World Genome Editing Enzymes Production by Region (Based on Production Site)
1.3.1 World Genome Editing Enzymes Production Value by Region (2021-2032)
1.3.2 World Genome Editing Enzymes Production by Region (2021-2032)
1.3.3 World Genome Editing Enzymes Average Price by Region (2021-2032)
1.3.4 North America Genome Editing Enzymes Production (2021-2032)
1.3.5 Europe Genome Editing Enzymes Production (2021-2032)
1.3.6 China Genome Editing Enzymes Production (2021-2032)
1.3.7 Japan Genome Editing Enzymes Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Genome Editing Enzymes Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Genome Editing Enzymes Major Market Trends
2 DEMAND SUMMARY
2.1 World Genome Editing Enzymes Demand (2021-2032)
2.2 World Genome Editing Enzymes Consumption by Region
2.2.1 World Genome Editing Enzymes Consumption by Region (2021-2026)
2.2.2 World Genome Editing Enzymes Consumption Forecast by Region (2027-2032)
2.3 United States Genome Editing Enzymes Consumption (2021-2032)
2.4 China Genome Editing Enzymes Consumption (2021-2032)
2.5 Europe Genome Editing Enzymes Consumption (2021-2032)
2.6 Japan Genome Editing Enzymes Consumption (2021-2032)
2.7 South Korea Genome Editing Enzymes Consumption (2021-2032)
2.8 ASEAN Genome Editing Enzymes Consumption (2021-2032)
2.9 India Genome Editing Enzymes Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Genome Editing Enzymes Production Value by Manufacturer (2021-2026)
3.2 World Genome Editing Enzymes Production by Manufacturer (2021-2026)
3.3 World Genome Editing Enzymes Average Price by Manufacturer (2021-2026)
3.4 Genome Editing Enzymes Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Genome Editing Enzymes Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Genome Editing Enzymes in 2025
3.5.3 Global Concentration Ratios (CR8) for Genome Editing Enzymes in 2025
3.6 Genome Editing Enzymes Market: Overall Company Footprint Analysis
3.6.1 Genome Editing Enzymes Market: Region Footprint
3.6.2 Genome Editing Enzymes Market: Company Product Type Footprint
3.6.3 Genome Editing Enzymes Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Genome Editing Enzymes Production Value Comparison
4.1.1 United States VS China: Genome Editing Enzymes Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Genome Editing Enzymes Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Genome Editing Enzymes Production Comparison
4.2.1 United States VS China: Genome Editing Enzymes Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Genome Editing Enzymes Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Genome Editing Enzymes Consumption Comparison
4.3.1 United States VS China: Genome Editing Enzymes Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Genome Editing Enzymes Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Genome Editing Enzymes Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Genome Editing Enzymes Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Genome Editing Enzymes Production Value (2021-2026)
4.4.3 United States Based Manufacturers Genome Editing Enzymes Production (2021-2026)
4.5 China Based Genome Editing Enzymes Manufacturers and Market Share
4.5.1 China Based Genome Editing Enzymes Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Genome Editing Enzymes Production Value (2021-2026)
4.5.3 China Based Manufacturers Genome Editing Enzymes Production (2021-2026)
4.6 Rest of World Based Genome Editing Enzymes Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Genome Editing Enzymes Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Genome Editing Enzymes Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Genome Editing Enzymes Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Genome Editing Enzymes Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 CRISPR-Associated (Cas) Enzymes
5.2.2 Base Editing Enzymes
5.2.3 Prime Editors
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Genome Editing Enzymes Production by Type (2021-2032)
5.3.2 World Genome Editing Enzymes Production Value by Type (2021-2032)
5.3.3 World Genome Editing Enzymes Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY STATE
6.1 World Genome Editing Enzymes Market Size Overview by State: 2021 VS 2025 VS 2032
6.2 Segment Introduction by State
6.2.1 Wild-Type Cleaving Nucleases
6.2.2 PAM-Engineered Nucleases
6.3 Market Segment by State
6.3.1 World Genome Editing Enzymes Production by State (2021-2032)
6.3.2 World Genome Editing Enzymes Production Value by State (2021-2032)
6.3.3 World Genome Editing Enzymes Average Price by State (2021-2032)
7 MARKET ANALYSIS BY QUALITY
7.1 World Genome Editing Enzymes Market Size Overview by Quality: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Quality
7.2.1 Research Use Grade
7.2.2 Process-Development Grade
7.3 Market Segment by Quality
7.3.1 World Genome Editing Enzymes Production by Quality (2021-2032)
7.3.2 World Genome Editing Enzymes Production Value by Quality (2021-2032)
7.3.3 World Genome Editing Enzymes Average Price by Quality (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Genome Editing Enzymes Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Basic Research
8.2.2 Biomedicine
8.2.3 Agriculture
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Genome Editing Enzymes Production by Application (2021-2032)
8.3.2 World Genome Editing Enzymes Production Value by Application (2021-2032)
8.3.3 World Genome Editing Enzymes Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Danaher Corporation
9.1.1 Danaher Corporation Details
9.1.2 Danaher Corporation Major Business
9.1.3 Danaher Corporation Genome Editing Enzymes Product and Services
9.1.4 Danaher Corporation Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Danaher Corporation Recent Developments/Updates
9.1.6 Danaher Corporation Competitive Strengths & Weaknesses
9.2 Thermo Fisher Scientific Inc.
9.2.1 Thermo Fisher Scientific Inc. Details
9.2.2 Thermo Fisher Scientific Inc. Major Business
9.2.3 Thermo Fisher Scientific Inc. Genome Editing Enzymes Product and Services
9.2.4 Thermo Fisher Scientific Inc. Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
9.2.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
9.3 Merck
9.3.1 Merck Details
9.3.2 Merck Major Business
9.3.3 Merck Genome Editing Enzymes Product and Services
9.3.4 Merck Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Merck Recent Developments/Updates
9.3.6 Merck Competitive Strengths & Weaknesses
9.4 New England Biolabs, Inc.
9.4.1 New England Biolabs, Inc. Details
9.4.2 New England Biolabs, Inc. Major Business
9.4.3 New England Biolabs, Inc. Genome Editing Enzymes Product and Services
9.4.4 New England Biolabs, Inc. Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 New England Biolabs, Inc. Recent Developments/Updates
9.4.6 New England Biolabs, Inc. Competitive Strengths & Weaknesses
9.5 Synthego Corporation
9.5.1 Synthego Corporation Details
9.5.2 Synthego Corporation Major Business
9.5.3 Synthego Corporation Genome Editing Enzymes Product and Services
9.5.4 Synthego Corporation Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Synthego Corporation Recent Developments/Updates
9.5.6 Synthego Corporation Competitive Strengths & Weaknesses
9.6 Takara Bio Inc.
9.6.1 Takara Bio Inc. Details
9.6.2 Takara Bio Inc. Major Business
9.6.3 Takara Bio Inc. Genome Editing Enzymes Product and Services
9.6.4 Takara Bio Inc. Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Takara Bio Inc. Recent Developments/Updates
9.6.6 Takara Bio Inc. Competitive Strengths & Weaknesses
9.7 Revvity, Inc.
9.7.1 Revvity, Inc. Details
9.7.2 Revvity, Inc. Major Business
9.7.3 Revvity, Inc. Genome Editing Enzymes Product and Services
9.7.4 Revvity, Inc. Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Revvity, Inc. Recent Developments/Updates
9.7.6 Revvity, Inc. Competitive Strengths & Weaknesses
9.8 ACROBiosystems Co., Ltd.
9.8.1 ACROBiosystems Co., Ltd. Details
9.8.2 ACROBiosystems Co., Ltd. Major Business
9.8.3 ACROBiosystems Co., Ltd. Genome Editing Enzymes Product and Services
9.8.4 ACROBiosystems Co., Ltd. Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 ACROBiosystems Co., Ltd. Recent Developments/Updates
9.8.6 ACROBiosystems Co., Ltd. Competitive Strengths & Weaknesses
9.9 Nanjing Vazyme Biotech Co., Ltd.
9.9.1 Nanjing Vazyme Biotech Co., Ltd. Details
9.9.2 Nanjing Vazyme Biotech Co., Ltd. Major Business
9.9.3 Nanjing Vazyme Biotech Co., Ltd. Genome Editing Enzymes Product and Services
9.9.4 Nanjing Vazyme Biotech Co., Ltd. Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Nanjing Vazyme Biotech Co., Ltd. Recent Developments/Updates
9.9.6 Nanjing Vazyme Biotech Co., Ltd. Competitive Strengths & Weaknesses
9.10 Suzhou Novoprotein Scientific Co., Ltd.
9.10.1 Suzhou Novoprotein Scientific Co., Ltd. Details
9.10.2 Suzhou Novoprotein Scientific Co., Ltd. Major Business
9.10.3 Suzhou Novoprotein Scientific Co., Ltd. Genome Editing Enzymes Product and Services
9.10.4 Suzhou Novoprotein Scientific Co., Ltd. Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Suzhou Novoprotein Scientific Co., Ltd. Recent Developments/Updates
9.10.6 Suzhou Novoprotein Scientific Co., Ltd. Competitive Strengths & Weaknesses
9.11 KACTUS Biotechnology
9.11.1 KACTUS Biotechnology Details
9.11.2 KACTUS Biotechnology Major Business
9.11.3 KACTUS Biotechnology Genome Editing Enzymes Product and Services
9.11.4 KACTUS Biotechnology Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 KACTUS Biotechnology Recent Developments/Updates
9.11.6 KACTUS Biotechnology Competitive Strengths & Weaknesses
9.12 Biomay AG
9.12.1 Biomay AG Details
9.12.2 Biomay AG Major Business
9.12.3 Biomay AG Genome Editing Enzymes Product and Services
9.12.4 Biomay AG Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Biomay AG Recent Developments/Updates
9.12.6 Biomay AG Competitive Strengths & Weaknesses
9.13 Yeasen Biotechnology
9.13.1 Yeasen Biotechnology Details
9.13.2 Yeasen Biotechnology Major Business
9.13.3 Yeasen Biotechnology Genome Editing Enzymes Product and Services
9.13.4 Yeasen Biotechnology Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Yeasen Biotechnology Recent Developments/Updates
9.13.6 Yeasen Biotechnology Competitive Strengths & Weaknesses
9.14 Tolo Biotech
9.14.1 Tolo Biotech Details
9.14.2 Tolo Biotech Major Business
9.14.3 Tolo Biotech Genome Editing Enzymes Product and Services
9.14.4 Tolo Biotech Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Tolo Biotech Recent Developments/Updates
9.14.6 Tolo Biotech Competitive Strengths & Weaknesses
9.15 BIONEER Corporation
9.15.1 BIONEER Corporation Details
9.15.2 BIONEER Corporation Major Business
9.15.3 BIONEER Corporation Genome Editing Enzymes Product and Services
9.15.4 BIONEER Corporation Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 BIONEER Corporation Recent Developments/Updates
9.15.6 BIONEER Corporation Competitive Strengths & Weaknesses
9.16 Agilent Technologies, Inc.
9.16.1 Agilent Technologies, Inc. Details
9.16.2 Agilent Technologies, Inc. Major Business
9.16.3 Agilent Technologies, Inc. Genome Editing Enzymes Product and Services
9.16.4 Agilent Technologies, Inc. Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Agilent Technologies, Inc. Recent Developments/Updates
9.16.6 Agilent Technologies, Inc. Competitive Strengths & Weaknesses
9.17 OriGene Technologies, Inc.
9.17.1 OriGene Technologies, Inc. Details
9.17.2 OriGene Technologies, Inc. Major Business
9.17.3 OriGene Technologies, Inc. Genome Editing Enzymes Product and Services
9.17.4 OriGene Technologies, Inc. Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 OriGene Technologies, Inc. Recent Developments/Updates
9.17.6 OriGene Technologies, Inc. Competitive Strengths & Weaknesses
9.18 Beyotime Biotechnology
9.18.1 Beyotime Biotechnology Details
9.18.2 Beyotime Biotechnology Major Business
9.18.3 Beyotime Biotechnology Genome Editing Enzymes Product and Services
9.18.4 Beyotime Biotechnology Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Beyotime Biotechnology Recent Developments/Updates
9.18.6 Beyotime Biotechnology Competitive Strengths & Weaknesses
9.19 Creative Enzymes
9.19.1 Creative Enzymes Details
9.19.2 Creative Enzymes Major Business
9.19.3 Creative Enzymes Genome Editing Enzymes Product and Services
9.19.4 Creative Enzymes Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Creative Enzymes Recent Developments/Updates
9.19.6 Creative Enzymes Competitive Strengths & Weaknesses
9.20 OZ Biosciences SAS
9.20.1 OZ Biosciences SAS Details
9.20.2 OZ Biosciences SAS Major Business
9.20.3 OZ Biosciences SAS Genome Editing Enzymes Product and Services
9.20.4 OZ Biosciences SAS Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 OZ Biosciences SAS Recent Developments/Updates
9.20.6 OZ Biosciences SAS Competitive Strengths & Weaknesses
9.21 Creative Biogene
9.21.1 Creative Biogene Details
9.21.2 Creative Biogene Major Business
9.21.3 Creative Biogene Genome Editing Enzymes Product and Services
9.21.4 Creative Biogene Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.21.5 Creative Biogene Recent Developments/Updates
9.21.6 Creative Biogene Competitive Strengths & Weaknesses
9.22 ProteoGenix SAS
9.22.1 ProteoGenix SAS Details
9.22.2 ProteoGenix SAS Major Business
9.22.3 ProteoGenix SAS Genome Editing Enzymes Product and Services
9.22.4 ProteoGenix SAS Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.22.5 ProteoGenix SAS Recent Developments/Updates
9.22.6 ProteoGenix SAS Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Genome Editing Enzymes Industry Chain
10.2 Genome Editing Enzymes Upstream Analysis
10.2.1 Genome Editing Enzymes Core Raw Materials
10.2.2 Main Manufacturers of Genome Editing Enzymes Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Genome Editing Enzymes Production Mode
10.6 Genome Editing Enzymes Procurement Model
10.7 Genome Editing Enzymes Industry Sales Model and Sales Channels
10.7.1 Genome Editing Enzymes Sales Model
10.7.2 Genome Editing Enzymes Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Genome Editing Enzymes Introduction
1.2 World Genome Editing Enzymes Supply & Forecast
1.2.1 World Genome Editing Enzymes Production Value (2021 & 2025 & 2032)
1.2.2 World Genome Editing Enzymes Production (2021-2032)
1.2.3 World Genome Editing Enzymes Pricing Trends (2021-2032)
1.3 World Genome Editing Enzymes Production by Region (Based on Production Site)
1.3.1 World Genome Editing Enzymes Production Value by Region (2021-2032)
1.3.2 World Genome Editing Enzymes Production by Region (2021-2032)
1.3.3 World Genome Editing Enzymes Average Price by Region (2021-2032)
1.3.4 North America Genome Editing Enzymes Production (2021-2032)
1.3.5 Europe Genome Editing Enzymes Production (2021-2032)
1.3.6 China Genome Editing Enzymes Production (2021-2032)
1.3.7 Japan Genome Editing Enzymes Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Genome Editing Enzymes Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Genome Editing Enzymes Major Market Trends
2 DEMAND SUMMARY
2.1 World Genome Editing Enzymes Demand (2021-2032)
2.2 World Genome Editing Enzymes Consumption by Region
2.2.1 World Genome Editing Enzymes Consumption by Region (2021-2026)
2.2.2 World Genome Editing Enzymes Consumption Forecast by Region (2027-2032)
2.3 United States Genome Editing Enzymes Consumption (2021-2032)
2.4 China Genome Editing Enzymes Consumption (2021-2032)
2.5 Europe Genome Editing Enzymes Consumption (2021-2032)
2.6 Japan Genome Editing Enzymes Consumption (2021-2032)
2.7 South Korea Genome Editing Enzymes Consumption (2021-2032)
2.8 ASEAN Genome Editing Enzymes Consumption (2021-2032)
2.9 India Genome Editing Enzymes Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Genome Editing Enzymes Production Value by Manufacturer (2021-2026)
3.2 World Genome Editing Enzymes Production by Manufacturer (2021-2026)
3.3 World Genome Editing Enzymes Average Price by Manufacturer (2021-2026)
3.4 Genome Editing Enzymes Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Genome Editing Enzymes Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Genome Editing Enzymes in 2025
3.5.3 Global Concentration Ratios (CR8) for Genome Editing Enzymes in 2025
3.6 Genome Editing Enzymes Market: Overall Company Footprint Analysis
3.6.1 Genome Editing Enzymes Market: Region Footprint
3.6.2 Genome Editing Enzymes Market: Company Product Type Footprint
3.6.3 Genome Editing Enzymes Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Genome Editing Enzymes Production Value Comparison
4.1.1 United States VS China: Genome Editing Enzymes Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Genome Editing Enzymes Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Genome Editing Enzymes Production Comparison
4.2.1 United States VS China: Genome Editing Enzymes Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Genome Editing Enzymes Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Genome Editing Enzymes Consumption Comparison
4.3.1 United States VS China: Genome Editing Enzymes Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Genome Editing Enzymes Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Genome Editing Enzymes Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Genome Editing Enzymes Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Genome Editing Enzymes Production Value (2021-2026)
4.4.3 United States Based Manufacturers Genome Editing Enzymes Production (2021-2026)
4.5 China Based Genome Editing Enzymes Manufacturers and Market Share
4.5.1 China Based Genome Editing Enzymes Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Genome Editing Enzymes Production Value (2021-2026)
4.5.3 China Based Manufacturers Genome Editing Enzymes Production (2021-2026)
4.6 Rest of World Based Genome Editing Enzymes Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Genome Editing Enzymes Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Genome Editing Enzymes Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Genome Editing Enzymes Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Genome Editing Enzymes Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 CRISPR-Associated (Cas) Enzymes
5.2.2 Base Editing Enzymes
5.2.3 Prime Editors
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Genome Editing Enzymes Production by Type (2021-2032)
5.3.2 World Genome Editing Enzymes Production Value by Type (2021-2032)
5.3.3 World Genome Editing Enzymes Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY STATE
6.1 World Genome Editing Enzymes Market Size Overview by State: 2021 VS 2025 VS 2032
6.2 Segment Introduction by State
6.2.1 Wild-Type Cleaving Nucleases
6.2.2 PAM-Engineered Nucleases
6.3 Market Segment by State
6.3.1 World Genome Editing Enzymes Production by State (2021-2032)
6.3.2 World Genome Editing Enzymes Production Value by State (2021-2032)
6.3.3 World Genome Editing Enzymes Average Price by State (2021-2032)
7 MARKET ANALYSIS BY QUALITY
7.1 World Genome Editing Enzymes Market Size Overview by Quality: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Quality
7.2.1 Research Use Grade
7.2.2 Process-Development Grade
7.3 Market Segment by Quality
7.3.1 World Genome Editing Enzymes Production by Quality (2021-2032)
7.3.2 World Genome Editing Enzymes Production Value by Quality (2021-2032)
7.3.3 World Genome Editing Enzymes Average Price by Quality (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Genome Editing Enzymes Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Basic Research
8.2.2 Biomedicine
8.2.3 Agriculture
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Genome Editing Enzymes Production by Application (2021-2032)
8.3.2 World Genome Editing Enzymes Production Value by Application (2021-2032)
8.3.3 World Genome Editing Enzymes Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Danaher Corporation
9.1.1 Danaher Corporation Details
9.1.2 Danaher Corporation Major Business
9.1.3 Danaher Corporation Genome Editing Enzymes Product and Services
9.1.4 Danaher Corporation Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Danaher Corporation Recent Developments/Updates
9.1.6 Danaher Corporation Competitive Strengths & Weaknesses
9.2 Thermo Fisher Scientific Inc.
9.2.1 Thermo Fisher Scientific Inc. Details
9.2.2 Thermo Fisher Scientific Inc. Major Business
9.2.3 Thermo Fisher Scientific Inc. Genome Editing Enzymes Product and Services
9.2.4 Thermo Fisher Scientific Inc. Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
9.2.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
9.3 Merck
9.3.1 Merck Details
9.3.2 Merck Major Business
9.3.3 Merck Genome Editing Enzymes Product and Services
9.3.4 Merck Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Merck Recent Developments/Updates
9.3.6 Merck Competitive Strengths & Weaknesses
9.4 New England Biolabs, Inc.
9.4.1 New England Biolabs, Inc. Details
9.4.2 New England Biolabs, Inc. Major Business
9.4.3 New England Biolabs, Inc. Genome Editing Enzymes Product and Services
9.4.4 New England Biolabs, Inc. Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 New England Biolabs, Inc. Recent Developments/Updates
9.4.6 New England Biolabs, Inc. Competitive Strengths & Weaknesses
9.5 Synthego Corporation
9.5.1 Synthego Corporation Details
9.5.2 Synthego Corporation Major Business
9.5.3 Synthego Corporation Genome Editing Enzymes Product and Services
9.5.4 Synthego Corporation Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Synthego Corporation Recent Developments/Updates
9.5.6 Synthego Corporation Competitive Strengths & Weaknesses
9.6 Takara Bio Inc.
9.6.1 Takara Bio Inc. Details
9.6.2 Takara Bio Inc. Major Business
9.6.3 Takara Bio Inc. Genome Editing Enzymes Product and Services
9.6.4 Takara Bio Inc. Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Takara Bio Inc. Recent Developments/Updates
9.6.6 Takara Bio Inc. Competitive Strengths & Weaknesses
9.7 Revvity, Inc.
9.7.1 Revvity, Inc. Details
9.7.2 Revvity, Inc. Major Business
9.7.3 Revvity, Inc. Genome Editing Enzymes Product and Services
9.7.4 Revvity, Inc. Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Revvity, Inc. Recent Developments/Updates
9.7.6 Revvity, Inc. Competitive Strengths & Weaknesses
9.8 ACROBiosystems Co., Ltd.
9.8.1 ACROBiosystems Co., Ltd. Details
9.8.2 ACROBiosystems Co., Ltd. Major Business
9.8.3 ACROBiosystems Co., Ltd. Genome Editing Enzymes Product and Services
9.8.4 ACROBiosystems Co., Ltd. Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 ACROBiosystems Co., Ltd. Recent Developments/Updates
9.8.6 ACROBiosystems Co., Ltd. Competitive Strengths & Weaknesses
9.9 Nanjing Vazyme Biotech Co., Ltd.
9.9.1 Nanjing Vazyme Biotech Co., Ltd. Details
9.9.2 Nanjing Vazyme Biotech Co., Ltd. Major Business
9.9.3 Nanjing Vazyme Biotech Co., Ltd. Genome Editing Enzymes Product and Services
9.9.4 Nanjing Vazyme Biotech Co., Ltd. Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Nanjing Vazyme Biotech Co., Ltd. Recent Developments/Updates
9.9.6 Nanjing Vazyme Biotech Co., Ltd. Competitive Strengths & Weaknesses
9.10 Suzhou Novoprotein Scientific Co., Ltd.
9.10.1 Suzhou Novoprotein Scientific Co., Ltd. Details
9.10.2 Suzhou Novoprotein Scientific Co., Ltd. Major Business
9.10.3 Suzhou Novoprotein Scientific Co., Ltd. Genome Editing Enzymes Product and Services
9.10.4 Suzhou Novoprotein Scientific Co., Ltd. Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Suzhou Novoprotein Scientific Co., Ltd. Recent Developments/Updates
9.10.6 Suzhou Novoprotein Scientific Co., Ltd. Competitive Strengths & Weaknesses
9.11 KACTUS Biotechnology
9.11.1 KACTUS Biotechnology Details
9.11.2 KACTUS Biotechnology Major Business
9.11.3 KACTUS Biotechnology Genome Editing Enzymes Product and Services
9.11.4 KACTUS Biotechnology Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 KACTUS Biotechnology Recent Developments/Updates
9.11.6 KACTUS Biotechnology Competitive Strengths & Weaknesses
9.12 Biomay AG
9.12.1 Biomay AG Details
9.12.2 Biomay AG Major Business
9.12.3 Biomay AG Genome Editing Enzymes Product and Services
9.12.4 Biomay AG Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Biomay AG Recent Developments/Updates
9.12.6 Biomay AG Competitive Strengths & Weaknesses
9.13 Yeasen Biotechnology
9.13.1 Yeasen Biotechnology Details
9.13.2 Yeasen Biotechnology Major Business
9.13.3 Yeasen Biotechnology Genome Editing Enzymes Product and Services
9.13.4 Yeasen Biotechnology Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Yeasen Biotechnology Recent Developments/Updates
9.13.6 Yeasen Biotechnology Competitive Strengths & Weaknesses
9.14 Tolo Biotech
9.14.1 Tolo Biotech Details
9.14.2 Tolo Biotech Major Business
9.14.3 Tolo Biotech Genome Editing Enzymes Product and Services
9.14.4 Tolo Biotech Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Tolo Biotech Recent Developments/Updates
9.14.6 Tolo Biotech Competitive Strengths & Weaknesses
9.15 BIONEER Corporation
9.15.1 BIONEER Corporation Details
9.15.2 BIONEER Corporation Major Business
9.15.3 BIONEER Corporation Genome Editing Enzymes Product and Services
9.15.4 BIONEER Corporation Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 BIONEER Corporation Recent Developments/Updates
9.15.6 BIONEER Corporation Competitive Strengths & Weaknesses
9.16 Agilent Technologies, Inc.
9.16.1 Agilent Technologies, Inc. Details
9.16.2 Agilent Technologies, Inc. Major Business
9.16.3 Agilent Technologies, Inc. Genome Editing Enzymes Product and Services
9.16.4 Agilent Technologies, Inc. Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Agilent Technologies, Inc. Recent Developments/Updates
9.16.6 Agilent Technologies, Inc. Competitive Strengths & Weaknesses
9.17 OriGene Technologies, Inc.
9.17.1 OriGene Technologies, Inc. Details
9.17.2 OriGene Technologies, Inc. Major Business
9.17.3 OriGene Technologies, Inc. Genome Editing Enzymes Product and Services
9.17.4 OriGene Technologies, Inc. Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 OriGene Technologies, Inc. Recent Developments/Updates
9.17.6 OriGene Technologies, Inc. Competitive Strengths & Weaknesses
9.18 Beyotime Biotechnology
9.18.1 Beyotime Biotechnology Details
9.18.2 Beyotime Biotechnology Major Business
9.18.3 Beyotime Biotechnology Genome Editing Enzymes Product and Services
9.18.4 Beyotime Biotechnology Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Beyotime Biotechnology Recent Developments/Updates
9.18.6 Beyotime Biotechnology Competitive Strengths & Weaknesses
9.19 Creative Enzymes
9.19.1 Creative Enzymes Details
9.19.2 Creative Enzymes Major Business
9.19.3 Creative Enzymes Genome Editing Enzymes Product and Services
9.19.4 Creative Enzymes Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Creative Enzymes Recent Developments/Updates
9.19.6 Creative Enzymes Competitive Strengths & Weaknesses
9.20 OZ Biosciences SAS
9.20.1 OZ Biosciences SAS Details
9.20.2 OZ Biosciences SAS Major Business
9.20.3 OZ Biosciences SAS Genome Editing Enzymes Product and Services
9.20.4 OZ Biosciences SAS Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 OZ Biosciences SAS Recent Developments/Updates
9.20.6 OZ Biosciences SAS Competitive Strengths & Weaknesses
9.21 Creative Biogene
9.21.1 Creative Biogene Details
9.21.2 Creative Biogene Major Business
9.21.3 Creative Biogene Genome Editing Enzymes Product and Services
9.21.4 Creative Biogene Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.21.5 Creative Biogene Recent Developments/Updates
9.21.6 Creative Biogene Competitive Strengths & Weaknesses
9.22 ProteoGenix SAS
9.22.1 ProteoGenix SAS Details
9.22.2 ProteoGenix SAS Major Business
9.22.3 ProteoGenix SAS Genome Editing Enzymes Product and Services
9.22.4 ProteoGenix SAS Genome Editing Enzymes Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.22.5 ProteoGenix SAS Recent Developments/Updates
9.22.6 ProteoGenix SAS Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Genome Editing Enzymes Industry Chain
10.2 Genome Editing Enzymes Upstream Analysis
10.2.1 Genome Editing Enzymes Core Raw Materials
10.2.2 Main Manufacturers of Genome Editing Enzymes Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Genome Editing Enzymes Production Mode
10.6 Genome Editing Enzymes Procurement Model
10.7 Genome Editing Enzymes Industry Sales Model and Sales Channels
10.7.1 Genome Editing Enzymes Sales Model
10.7.2 Genome Editing Enzymes Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Genome Editing Enzymes Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Genome Editing Enzymes Production Value by Region (2021-2026) & (USD Million)
Table 3. World Genome Editing Enzymes Production Value by Region (2027-2032) & (USD Million)
Table 4. World Genome Editing Enzymes Production Value Market Share by Region (2021-2026)
Table 5. World Genome Editing Enzymes Production Value Market Share by Region (2027-2032)
Table 6. World Genome Editing Enzymes Production by Region (2021-2026) & (µg)
Table 7. World Genome Editing Enzymes Production by Region (2027-2032) & (µg)
Table 8. World Genome Editing Enzymes Production Market Share by Region (2021-2026)
Table 9. World Genome Editing Enzymes Production Market Share by Region (2027-2032)
Table 10. World Genome Editing Enzymes Average Price by Region (2021-2026) & (US$/µg)
Table 11. World Genome Editing Enzymes Average Price by Region (2027-2032) & (US$/µg)
Table 12. Genome Editing Enzymes Major Market Trends
Table 13. World Genome Editing Enzymes Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (µg)
Table 14. World Genome Editing Enzymes Consumption by Region (2021-2026) & (µg)
Table 15. World Genome Editing Enzymes Consumption Forecast by Region (2027-2032) & (µg)
Table 16. World Genome Editing Enzymes Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Genome Editing Enzymes Producers in 2025
Table 18. World Genome Editing Enzymes Production by Manufacturer (2021-2026) & (µg)
Table 19. Production Market Share of Key Genome Editing Enzymes Producers in 2025
Table 20. World Genome Editing Enzymes Average Price by Manufacturer (2021-2026) & (US$/µg)
Table 21. Global Genome Editing Enzymes Company Evaluation Quadrant
Table 22. World Genome Editing Enzymes Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Genome Editing Enzymes Production Site of Key Manufacturer
Table 24. Genome Editing Enzymes Market: Company Product Type Footprint
Table 25. Genome Editing Enzymes Market: Company Product Application Footprint
Table 26. Genome Editing Enzymes Competitive Factors
Table 27. Genome Editing Enzymes New Entrant and Capacity Expansion Plans
Table 28. Genome Editing Enzymes Mergers & Acquisitions Activity
Table 29. United States VS China Genome Editing Enzymes Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Genome Editing Enzymes Production Comparison, (2021 & 2025 & 2032) & (µg)
Table 31. United States VS China Genome Editing Enzymes Consumption Comparison, (2021 & 2025 & 2032) & (µg)
Table 32. United States Based Genome Editing Enzymes Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Genome Editing Enzymes Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Genome Editing Enzymes Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Genome Editing Enzymes Production (2021-2026) & (µg)
Table 36. United States Based Manufacturers Genome Editing Enzymes Production Market Share (2021-2026)
Table 37. China Based Genome Editing Enzymes Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Genome Editing Enzymes Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Genome Editing Enzymes Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Genome Editing Enzymes Production, (2021-2026) & (µg)
Table 41. China Based Manufacturers Genome Editing Enzymes Production Market Share (2021-2026)
Table 42. Rest of World Based Genome Editing Enzymes Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Genome Editing Enzymes Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Genome Editing Enzymes Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Genome Editing Enzymes Production, (2021-2026) & (µg)
Table 46. Rest of World Based Manufacturers Genome Editing Enzymes Production Market Share (2021-2026)
Table 47. World Genome Editing Enzymes Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Genome Editing Enzymes Production by Type (2021-2026) & (µg)
Table 49. World Genome Editing Enzymes Production by Type (2027-2032) & (µg)
Table 50. World Genome Editing Enzymes Production Value by Type (2021-2026) & (USD Million)
Table 51. World Genome Editing Enzymes Production Value by Type (2027-2032) & (USD Million)
Table 52. World Genome Editing Enzymes Average Price by Type (2021-2026) & (US$/µg)
Table 53. World Genome Editing Enzymes Average Price by Type (2027-2032) & (US$/µg)
Table 54. World Genome Editing Enzymes Production Value by State, (USD Million), 2021 & 2025 & 2032
Table 55. World Genome Editing Enzymes Production by State (2021-2026) & (µg)
Table 56. World Genome Editing Enzymes Production by State (2027-2032) & (µg)
Table 57. World Genome Editing Enzymes Production Value by State (2021-2026) & (USD Million)
Table 58. World Genome Editing Enzymes Production Value by State (2027-2032) & (USD Million)
Table 59. World Genome Editing Enzymes Average Price by State (2021-2026) & (US$/µg)
Table 60. World Genome Editing Enzymes Average Price by State (2027-2032) & (US$/µg)
Table 61. World Genome Editing Enzymes Production Value by Quality, (USD Million), 2021 & 2025 & 2032
Table 62. World Genome Editing Enzymes Production by Quality (2021-2026) & (µg)
Table 63. World Genome Editing Enzymes Production by Quality (2027-2032) & (µg)
Table 64. World Genome Editing Enzymes Production Value by Quality (2021-2026) & (USD Million)
Table 65. World Genome Editing Enzymes Production Value by Quality (2027-2032) & (USD Million)
Table 66. World Genome Editing Enzymes Average Price by Quality (2021-2026) & (US$/µg)
Table 67. World Genome Editing Enzymes Average Price by Quality (2027-2032) & (US$/µg)
Table 68. World Genome Editing Enzymes Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Genome Editing Enzymes Production by Application (2021-2026) & (µg)
Table 70. World Genome Editing Enzymes Production by Application (2027-2032) & (µg)
Table 71. World Genome Editing Enzymes Production Value by Application (2021-2026) & (USD Million)
Table 72. World Genome Editing Enzymes Production Value by Application (2027-2032) & (USD Million)
Table 73. World Genome Editing Enzymes Average Price by Application (2021-2026) & (US$/µg)
Table 74. World Genome Editing Enzymes Average Price by Application (2027-2032) & (US$/µg)
Table 75. Danaher Corporation Basic Information, Manufacturing Base and Competitors
Table 76. Danaher Corporation Major Business
Table 77. Danaher Corporation Genome Editing Enzymes Product and Services
Table 78. Danaher Corporation Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Danaher Corporation Recent Developments/Updates
Table 80. Danaher Corporation Competitive Strengths & Weaknesses
Table 81. Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table 82. Thermo Fisher Scientific Inc. Major Business
Table 83. Thermo Fisher Scientific Inc. Genome Editing Enzymes Product and Services
Table 84. Thermo Fisher Scientific Inc. Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 86. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 87. Merck Basic Information, Manufacturing Base and Competitors
Table 88. Merck Major Business
Table 89. Merck Genome Editing Enzymes Product and Services
Table 90. Merck Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Merck Recent Developments/Updates
Table 92. Merck Competitive Strengths & Weaknesses
Table 93. New England Biolabs, Inc. Basic Information, Manufacturing Base and Competitors
Table 94. New England Biolabs, Inc. Major Business
Table 95. New England Biolabs, Inc. Genome Editing Enzymes Product and Services
Table 96. New England Biolabs, Inc. Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. New England Biolabs, Inc. Recent Developments/Updates
Table 98. New England Biolabs, Inc. Competitive Strengths & Weaknesses
Table 99. Synthego Corporation Basic Information, Manufacturing Base and Competitors
Table 100. Synthego Corporation Major Business
Table 101. Synthego Corporation Genome Editing Enzymes Product and Services
Table 102. Synthego Corporation Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Synthego Corporation Recent Developments/Updates
Table 104. Synthego Corporation Competitive Strengths & Weaknesses
Table 105. Takara Bio Inc. Basic Information, Manufacturing Base and Competitors
Table 106. Takara Bio Inc. Major Business
Table 107. Takara Bio Inc. Genome Editing Enzymes Product and Services
Table 108. Takara Bio Inc. Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Takara Bio Inc. Recent Developments/Updates
Table 110. Takara Bio Inc. Competitive Strengths & Weaknesses
Table 111. Revvity, Inc. Basic Information, Manufacturing Base and Competitors
Table 112. Revvity, Inc. Major Business
Table 113. Revvity, Inc. Genome Editing Enzymes Product and Services
Table 114. Revvity, Inc. Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Revvity, Inc. Recent Developments/Updates
Table 116. Revvity, Inc. Competitive Strengths & Weaknesses
Table 117. ACROBiosystems Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 118. ACROBiosystems Co., Ltd. Major Business
Table 119. ACROBiosystems Co., Ltd. Genome Editing Enzymes Product and Services
Table 120. ACROBiosystems Co., Ltd. Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. ACROBiosystems Co., Ltd. Recent Developments/Updates
Table 122. ACROBiosystems Co., Ltd. Competitive Strengths & Weaknesses
Table 123. Nanjing Vazyme Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 124. Nanjing Vazyme Biotech Co., Ltd. Major Business
Table 125. Nanjing Vazyme Biotech Co., Ltd. Genome Editing Enzymes Product and Services
Table 126. Nanjing Vazyme Biotech Co., Ltd. Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Nanjing Vazyme Biotech Co., Ltd. Recent Developments/Updates
Table 128. Nanjing Vazyme Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 129. Suzhou Novoprotein Scientific Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 130. Suzhou Novoprotein Scientific Co., Ltd. Major Business
Table 131. Suzhou Novoprotein Scientific Co., Ltd. Genome Editing Enzymes Product and Services
Table 132. Suzhou Novoprotein Scientific Co., Ltd. Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Suzhou Novoprotein Scientific Co., Ltd. Recent Developments/Updates
Table 134. Suzhou Novoprotein Scientific Co., Ltd. Competitive Strengths & Weaknesses
Table 135. KACTUS Biotechnology Basic Information, Manufacturing Base and Competitors
Table 136. KACTUS Biotechnology Major Business
Table 137. KACTUS Biotechnology Genome Editing Enzymes Product and Services
Table 138. KACTUS Biotechnology Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. KACTUS Biotechnology Recent Developments/Updates
Table 140. KACTUS Biotechnology Competitive Strengths & Weaknesses
Table 141. Biomay AG Basic Information, Manufacturing Base and Competitors
Table 142. Biomay AG Major Business
Table 143. Biomay AG Genome Editing Enzymes Product and Services
Table 144. Biomay AG Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Biomay AG Recent Developments/Updates
Table 146. Biomay AG Competitive Strengths & Weaknesses
Table 147. Yeasen Biotechnology Basic Information, Manufacturing Base and Competitors
Table 148. Yeasen Biotechnology Major Business
Table 149. Yeasen Biotechnology Genome Editing Enzymes Product and Services
Table 150. Yeasen Biotechnology Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Yeasen Biotechnology Recent Developments/Updates
Table 152. Yeasen Biotechnology Competitive Strengths & Weaknesses
Table 153. Tolo Biotech Basic Information, Manufacturing Base and Competitors
Table 154. Tolo Biotech Major Business
Table 155. Tolo Biotech Genome Editing Enzymes Product and Services
Table 156. Tolo Biotech Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Tolo Biotech Recent Developments/Updates
Table 158. Tolo Biotech Competitive Strengths & Weaknesses
Table 159. BIONEER Corporation Basic Information, Manufacturing Base and Competitors
Table 160. BIONEER Corporation Major Business
Table 161. BIONEER Corporation Genome Editing Enzymes Product and Services
Table 162. BIONEER Corporation Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. BIONEER Corporation Recent Developments/Updates
Table 164. BIONEER Corporation Competitive Strengths & Weaknesses
Table 165. Agilent Technologies, Inc. Basic Information, Manufacturing Base and Competitors
Table 166. Agilent Technologies, Inc. Major Business
Table 167. Agilent Technologies, Inc. Genome Editing Enzymes Product and Services
Table 168. Agilent Technologies, Inc. Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Agilent Technologies, Inc. Recent Developments/Updates
Table 170. Agilent Technologies, Inc. Competitive Strengths & Weaknesses
Table 171. OriGene Technologies, Inc. Basic Information, Manufacturing Base and Competitors
Table 172. OriGene Technologies, Inc. Major Business
Table 173. OriGene Technologies, Inc. Genome Editing Enzymes Product and Services
Table 174. OriGene Technologies, Inc. Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. OriGene Technologies, Inc. Recent Developments/Updates
Table 176. OriGene Technologies, Inc. Competitive Strengths & Weaknesses
Table 177. Beyotime Biotechnology Basic Information, Manufacturing Base and Competitors
Table 178. Beyotime Biotechnology Major Business
Table 179. Beyotime Biotechnology Genome Editing Enzymes Product and Services
Table 180. Beyotime Biotechnology Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Beyotime Biotechnology Recent Developments/Updates
Table 182. Beyotime Biotechnology Competitive Strengths & Weaknesses
Table 183. Creative Enzymes Basic Information, Manufacturing Base and Competitors
Table 184. Creative Enzymes Major Business
Table 185. Creative Enzymes Genome Editing Enzymes Product and Services
Table 186. Creative Enzymes Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Creative Enzymes Recent Developments/Updates
Table 188. Creative Enzymes Competitive Strengths & Weaknesses
Table 189. OZ Biosciences SAS Basic Information, Manufacturing Base and Competitors
Table 190. OZ Biosciences SAS Major Business
Table 191. OZ Biosciences SAS Genome Editing Enzymes Product and Services
Table 192. OZ Biosciences SAS Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. OZ Biosciences SAS Recent Developments/Updates
Table 194. OZ Biosciences SAS Competitive Strengths & Weaknesses
Table 195. Creative Biogene Basic Information, Manufacturing Base and Competitors
Table 196. Creative Biogene Major Business
Table 197. Creative Biogene Genome Editing Enzymes Product and Services
Table 198. Creative Biogene Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 199. Creative Biogene Recent Developments/Updates
Table 200. Creative Biogene Competitive Strengths & Weaknesses
Table 201. ProteoGenix SAS Basic Information, Manufacturing Base and Competitors
Table 202. ProteoGenix SAS Major Business
Table 203. ProteoGenix SAS Genome Editing Enzymes Product and Services
Table 204. ProteoGenix SAS Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. ProteoGenix SAS Recent Developments/Updates
Table 206. ProteoGenix SAS Competitive Strengths & Weaknesses
Table 207. Global Key Players of Genome Editing Enzymes Upstream (Raw Materials)
Table 208. Global Genome Editing Enzymes Typical Customers
Table 209. Genome Editing Enzymes Typical Distributors
Table 1. World Genome Editing Enzymes Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Genome Editing Enzymes Production Value by Region (2021-2026) & (USD Million)
Table 3. World Genome Editing Enzymes Production Value by Region (2027-2032) & (USD Million)
Table 4. World Genome Editing Enzymes Production Value Market Share by Region (2021-2026)
Table 5. World Genome Editing Enzymes Production Value Market Share by Region (2027-2032)
Table 6. World Genome Editing Enzymes Production by Region (2021-2026) & (µg)
Table 7. World Genome Editing Enzymes Production by Region (2027-2032) & (µg)
Table 8. World Genome Editing Enzymes Production Market Share by Region (2021-2026)
Table 9. World Genome Editing Enzymes Production Market Share by Region (2027-2032)
Table 10. World Genome Editing Enzymes Average Price by Region (2021-2026) & (US$/µg)
Table 11. World Genome Editing Enzymes Average Price by Region (2027-2032) & (US$/µg)
Table 12. Genome Editing Enzymes Major Market Trends
Table 13. World Genome Editing Enzymes Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (µg)
Table 14. World Genome Editing Enzymes Consumption by Region (2021-2026) & (µg)
Table 15. World Genome Editing Enzymes Consumption Forecast by Region (2027-2032) & (µg)
Table 16. World Genome Editing Enzymes Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Genome Editing Enzymes Producers in 2025
Table 18. World Genome Editing Enzymes Production by Manufacturer (2021-2026) & (µg)
Table 19. Production Market Share of Key Genome Editing Enzymes Producers in 2025
Table 20. World Genome Editing Enzymes Average Price by Manufacturer (2021-2026) & (US$/µg)
Table 21. Global Genome Editing Enzymes Company Evaluation Quadrant
Table 22. World Genome Editing Enzymes Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Genome Editing Enzymes Production Site of Key Manufacturer
Table 24. Genome Editing Enzymes Market: Company Product Type Footprint
Table 25. Genome Editing Enzymes Market: Company Product Application Footprint
Table 26. Genome Editing Enzymes Competitive Factors
Table 27. Genome Editing Enzymes New Entrant and Capacity Expansion Plans
Table 28. Genome Editing Enzymes Mergers & Acquisitions Activity
Table 29. United States VS China Genome Editing Enzymes Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Genome Editing Enzymes Production Comparison, (2021 & 2025 & 2032) & (µg)
Table 31. United States VS China Genome Editing Enzymes Consumption Comparison, (2021 & 2025 & 2032) & (µg)
Table 32. United States Based Genome Editing Enzymes Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Genome Editing Enzymes Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Genome Editing Enzymes Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Genome Editing Enzymes Production (2021-2026) & (µg)
Table 36. United States Based Manufacturers Genome Editing Enzymes Production Market Share (2021-2026)
Table 37. China Based Genome Editing Enzymes Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Genome Editing Enzymes Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Genome Editing Enzymes Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Genome Editing Enzymes Production, (2021-2026) & (µg)
Table 41. China Based Manufacturers Genome Editing Enzymes Production Market Share (2021-2026)
Table 42. Rest of World Based Genome Editing Enzymes Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Genome Editing Enzymes Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Genome Editing Enzymes Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Genome Editing Enzymes Production, (2021-2026) & (µg)
Table 46. Rest of World Based Manufacturers Genome Editing Enzymes Production Market Share (2021-2026)
Table 47. World Genome Editing Enzymes Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Genome Editing Enzymes Production by Type (2021-2026) & (µg)
Table 49. World Genome Editing Enzymes Production by Type (2027-2032) & (µg)
Table 50. World Genome Editing Enzymes Production Value by Type (2021-2026) & (USD Million)
Table 51. World Genome Editing Enzymes Production Value by Type (2027-2032) & (USD Million)
Table 52. World Genome Editing Enzymes Average Price by Type (2021-2026) & (US$/µg)
Table 53. World Genome Editing Enzymes Average Price by Type (2027-2032) & (US$/µg)
Table 54. World Genome Editing Enzymes Production Value by State, (USD Million), 2021 & 2025 & 2032
Table 55. World Genome Editing Enzymes Production by State (2021-2026) & (µg)
Table 56. World Genome Editing Enzymes Production by State (2027-2032) & (µg)
Table 57. World Genome Editing Enzymes Production Value by State (2021-2026) & (USD Million)
Table 58. World Genome Editing Enzymes Production Value by State (2027-2032) & (USD Million)
Table 59. World Genome Editing Enzymes Average Price by State (2021-2026) & (US$/µg)
Table 60. World Genome Editing Enzymes Average Price by State (2027-2032) & (US$/µg)
Table 61. World Genome Editing Enzymes Production Value by Quality, (USD Million), 2021 & 2025 & 2032
Table 62. World Genome Editing Enzymes Production by Quality (2021-2026) & (µg)
Table 63. World Genome Editing Enzymes Production by Quality (2027-2032) & (µg)
Table 64. World Genome Editing Enzymes Production Value by Quality (2021-2026) & (USD Million)
Table 65. World Genome Editing Enzymes Production Value by Quality (2027-2032) & (USD Million)
Table 66. World Genome Editing Enzymes Average Price by Quality (2021-2026) & (US$/µg)
Table 67. World Genome Editing Enzymes Average Price by Quality (2027-2032) & (US$/µg)
Table 68. World Genome Editing Enzymes Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Genome Editing Enzymes Production by Application (2021-2026) & (µg)
Table 70. World Genome Editing Enzymes Production by Application (2027-2032) & (µg)
Table 71. World Genome Editing Enzymes Production Value by Application (2021-2026) & (USD Million)
Table 72. World Genome Editing Enzymes Production Value by Application (2027-2032) & (USD Million)
Table 73. World Genome Editing Enzymes Average Price by Application (2021-2026) & (US$/µg)
Table 74. World Genome Editing Enzymes Average Price by Application (2027-2032) & (US$/µg)
Table 75. Danaher Corporation Basic Information, Manufacturing Base and Competitors
Table 76. Danaher Corporation Major Business
Table 77. Danaher Corporation Genome Editing Enzymes Product and Services
Table 78. Danaher Corporation Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Danaher Corporation Recent Developments/Updates
Table 80. Danaher Corporation Competitive Strengths & Weaknesses
Table 81. Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base and Competitors
Table 82. Thermo Fisher Scientific Inc. Major Business
Table 83. Thermo Fisher Scientific Inc. Genome Editing Enzymes Product and Services
Table 84. Thermo Fisher Scientific Inc. Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Thermo Fisher Scientific Inc. Recent Developments/Updates
Table 86. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
Table 87. Merck Basic Information, Manufacturing Base and Competitors
Table 88. Merck Major Business
Table 89. Merck Genome Editing Enzymes Product and Services
Table 90. Merck Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Merck Recent Developments/Updates
Table 92. Merck Competitive Strengths & Weaknesses
Table 93. New England Biolabs, Inc. Basic Information, Manufacturing Base and Competitors
Table 94. New England Biolabs, Inc. Major Business
Table 95. New England Biolabs, Inc. Genome Editing Enzymes Product and Services
Table 96. New England Biolabs, Inc. Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. New England Biolabs, Inc. Recent Developments/Updates
Table 98. New England Biolabs, Inc. Competitive Strengths & Weaknesses
Table 99. Synthego Corporation Basic Information, Manufacturing Base and Competitors
Table 100. Synthego Corporation Major Business
Table 101. Synthego Corporation Genome Editing Enzymes Product and Services
Table 102. Synthego Corporation Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Synthego Corporation Recent Developments/Updates
Table 104. Synthego Corporation Competitive Strengths & Weaknesses
Table 105. Takara Bio Inc. Basic Information, Manufacturing Base and Competitors
Table 106. Takara Bio Inc. Major Business
Table 107. Takara Bio Inc. Genome Editing Enzymes Product and Services
Table 108. Takara Bio Inc. Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Takara Bio Inc. Recent Developments/Updates
Table 110. Takara Bio Inc. Competitive Strengths & Weaknesses
Table 111. Revvity, Inc. Basic Information, Manufacturing Base and Competitors
Table 112. Revvity, Inc. Major Business
Table 113. Revvity, Inc. Genome Editing Enzymes Product and Services
Table 114. Revvity, Inc. Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Revvity, Inc. Recent Developments/Updates
Table 116. Revvity, Inc. Competitive Strengths & Weaknesses
Table 117. ACROBiosystems Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 118. ACROBiosystems Co., Ltd. Major Business
Table 119. ACROBiosystems Co., Ltd. Genome Editing Enzymes Product and Services
Table 120. ACROBiosystems Co., Ltd. Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. ACROBiosystems Co., Ltd. Recent Developments/Updates
Table 122. ACROBiosystems Co., Ltd. Competitive Strengths & Weaknesses
Table 123. Nanjing Vazyme Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 124. Nanjing Vazyme Biotech Co., Ltd. Major Business
Table 125. Nanjing Vazyme Biotech Co., Ltd. Genome Editing Enzymes Product and Services
Table 126. Nanjing Vazyme Biotech Co., Ltd. Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Nanjing Vazyme Biotech Co., Ltd. Recent Developments/Updates
Table 128. Nanjing Vazyme Biotech Co., Ltd. Competitive Strengths & Weaknesses
Table 129. Suzhou Novoprotein Scientific Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 130. Suzhou Novoprotein Scientific Co., Ltd. Major Business
Table 131. Suzhou Novoprotein Scientific Co., Ltd. Genome Editing Enzymes Product and Services
Table 132. Suzhou Novoprotein Scientific Co., Ltd. Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Suzhou Novoprotein Scientific Co., Ltd. Recent Developments/Updates
Table 134. Suzhou Novoprotein Scientific Co., Ltd. Competitive Strengths & Weaknesses
Table 135. KACTUS Biotechnology Basic Information, Manufacturing Base and Competitors
Table 136. KACTUS Biotechnology Major Business
Table 137. KACTUS Biotechnology Genome Editing Enzymes Product and Services
Table 138. KACTUS Biotechnology Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. KACTUS Biotechnology Recent Developments/Updates
Table 140. KACTUS Biotechnology Competitive Strengths & Weaknesses
Table 141. Biomay AG Basic Information, Manufacturing Base and Competitors
Table 142. Biomay AG Major Business
Table 143. Biomay AG Genome Editing Enzymes Product and Services
Table 144. Biomay AG Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Biomay AG Recent Developments/Updates
Table 146. Biomay AG Competitive Strengths & Weaknesses
Table 147. Yeasen Biotechnology Basic Information, Manufacturing Base and Competitors
Table 148. Yeasen Biotechnology Major Business
Table 149. Yeasen Biotechnology Genome Editing Enzymes Product and Services
Table 150. Yeasen Biotechnology Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Yeasen Biotechnology Recent Developments/Updates
Table 152. Yeasen Biotechnology Competitive Strengths & Weaknesses
Table 153. Tolo Biotech Basic Information, Manufacturing Base and Competitors
Table 154. Tolo Biotech Major Business
Table 155. Tolo Biotech Genome Editing Enzymes Product and Services
Table 156. Tolo Biotech Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Tolo Biotech Recent Developments/Updates
Table 158. Tolo Biotech Competitive Strengths & Weaknesses
Table 159. BIONEER Corporation Basic Information, Manufacturing Base and Competitors
Table 160. BIONEER Corporation Major Business
Table 161. BIONEER Corporation Genome Editing Enzymes Product and Services
Table 162. BIONEER Corporation Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. BIONEER Corporation Recent Developments/Updates
Table 164. BIONEER Corporation Competitive Strengths & Weaknesses
Table 165. Agilent Technologies, Inc. Basic Information, Manufacturing Base and Competitors
Table 166. Agilent Technologies, Inc. Major Business
Table 167. Agilent Technologies, Inc. Genome Editing Enzymes Product and Services
Table 168. Agilent Technologies, Inc. Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Agilent Technologies, Inc. Recent Developments/Updates
Table 170. Agilent Technologies, Inc. Competitive Strengths & Weaknesses
Table 171. OriGene Technologies, Inc. Basic Information, Manufacturing Base and Competitors
Table 172. OriGene Technologies, Inc. Major Business
Table 173. OriGene Technologies, Inc. Genome Editing Enzymes Product and Services
Table 174. OriGene Technologies, Inc. Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. OriGene Technologies, Inc. Recent Developments/Updates
Table 176. OriGene Technologies, Inc. Competitive Strengths & Weaknesses
Table 177. Beyotime Biotechnology Basic Information, Manufacturing Base and Competitors
Table 178. Beyotime Biotechnology Major Business
Table 179. Beyotime Biotechnology Genome Editing Enzymes Product and Services
Table 180. Beyotime Biotechnology Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Beyotime Biotechnology Recent Developments/Updates
Table 182. Beyotime Biotechnology Competitive Strengths & Weaknesses
Table 183. Creative Enzymes Basic Information, Manufacturing Base and Competitors
Table 184. Creative Enzymes Major Business
Table 185. Creative Enzymes Genome Editing Enzymes Product and Services
Table 186. Creative Enzymes Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Creative Enzymes Recent Developments/Updates
Table 188. Creative Enzymes Competitive Strengths & Weaknesses
Table 189. OZ Biosciences SAS Basic Information, Manufacturing Base and Competitors
Table 190. OZ Biosciences SAS Major Business
Table 191. OZ Biosciences SAS Genome Editing Enzymes Product and Services
Table 192. OZ Biosciences SAS Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. OZ Biosciences SAS Recent Developments/Updates
Table 194. OZ Biosciences SAS Competitive Strengths & Weaknesses
Table 195. Creative Biogene Basic Information, Manufacturing Base and Competitors
Table 196. Creative Biogene Major Business
Table 197. Creative Biogene Genome Editing Enzymes Product and Services
Table 198. Creative Biogene Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 199. Creative Biogene Recent Developments/Updates
Table 200. Creative Biogene Competitive Strengths & Weaknesses
Table 201. ProteoGenix SAS Basic Information, Manufacturing Base and Competitors
Table 202. ProteoGenix SAS Major Business
Table 203. ProteoGenix SAS Genome Editing Enzymes Product and Services
Table 204. ProteoGenix SAS Genome Editing Enzymes Production (µg), Price (US$/µg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. ProteoGenix SAS Recent Developments/Updates
Table 206. ProteoGenix SAS Competitive Strengths & Weaknesses
Table 207. Global Key Players of Genome Editing Enzymes Upstream (Raw Materials)
Table 208. Global Genome Editing Enzymes Typical Customers
Table 209. Genome Editing Enzymes Typical Distributors
LIST OF FIGURES
Figure 1. Genome Editing Enzymes Picture
Figure 2. World Genome Editing Enzymes Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Genome Editing Enzymes Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Genome Editing Enzymes Production (2021-2032) & (µg)
Figure 5. World Genome Editing Enzymes Average Price (2021-2032) & (US$/µg)
Figure 6. World Genome Editing Enzymes Production Value Market Share by Region (2021-2032)
Figure 7. World Genome Editing Enzymes Production Market Share by Region (2021-2032)
Figure 8. North America Genome Editing Enzymes Production (2021-2032) & (µg)
Figure 9. Europe Genome Editing Enzymes Production (2021-2032) & (µg)
Figure 10. China Genome Editing Enzymes Production (2021-2032) & (µg)
Figure 11. Japan Genome Editing Enzymes Production (2021-2032) & (µg)
Figure 12. Genome Editing Enzymes Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Genome Editing Enzymes Consumption (2021-2032) & (µg)
Figure 15. World Genome Editing Enzymes Consumption Market Share by Region (2021-2032)
Figure 16. United States Genome Editing Enzymes Consumption (2021-2032) & (µg)
Figure 17. China Genome Editing Enzymes Consumption (2021-2032) & (µg)
Figure 18. Europe Genome Editing Enzymes Consumption (2021-2032) & (µg)
Figure 19. Japan Genome Editing Enzymes Consumption (2021-2032) & (µg)
Figure 20. South Korea Genome Editing Enzymes Consumption (2021-2032) & (µg)
Figure 21. ASEAN Genome Editing Enzymes Consumption (2021-2032) & (µg)
Figure 22. India Genome Editing Enzymes Consumption (2021-2032) & (µg)
Figure 23. Producer Shipments of Genome Editing Enzymes by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Genome Editing Enzymes Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Genome Editing Enzymes Markets in 2025
Figure 26. United States VS China: Genome Editing Enzymes Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Genome Editing Enzymes Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Genome Editing Enzymes Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Genome Editing Enzymes Production Market Share 2025
Figure 30. China Based Manufacturers Genome Editing Enzymes Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Genome Editing Enzymes Production Market Share 2025
Figure 32. World Genome Editing Enzymes Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Genome Editing Enzymes Production Value Market Share by Type in 2025
Figure 34. CRISPR-Associated (Cas) Enzymes
Figure 35. Base Editing Enzymes
Figure 36. Prime Editors
Figure 37. Others
Figure 38. World Genome Editing Enzymes Production Market Share by Type (2021-2032)
Figure 39. World Genome Editing Enzymes Production Value Market Share by Type (2021-2032)
Figure 40. World Genome Editing Enzymes Average Price by Type (2021-2032) & (US$/µg)
Figure 41. World Genome Editing Enzymes Production Value by State, (USD Million), 2021 & 2025 & 2032
Figure 42. World Genome Editing Enzymes Production Value Market Share by State in 2025
Figure 43. Wild-Type Cleaving Nucleases
Figure 44. PAM-Engineered Nucleases
Figure 45. World Genome Editing Enzymes Production Market Share by State (2021-2032)
Figure 46. World Genome Editing Enzymes Production Value Market Share by State (2021-2032)
Figure 47. World Genome Editing Enzymes Average Price by State (2021-2032) & (US$/µg)
Figure 48. World Genome Editing Enzymes Production Value by Quality, (USD Million), 2021 & 2025 & 2032
Figure 49. World Genome Editing Enzymes Production Value Market Share by Quality in 2025
Figure 50. Research Use Grade
Figure 51. Process-Development Grade
Figure 52. World Genome Editing Enzymes Production Market Share by Quality (2021-2032)
Figure 53. World Genome Editing Enzymes Production Value Market Share by Quality (2021-2032)
Figure 54. World Genome Editing Enzymes Average Price by Quality (2021-2032) & (US$/µg)
Figure 55. World Genome Editing Enzymes Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Genome Editing Enzymes Production Value Market Share by Application in 2025
Figure 57. Basic Research
Figure 58. Biomedicine
Figure 59. Agriculture
Figure 60. Others
Figure 61. World Genome Editing Enzymes Production Market Share by Application (2021-2032)
Figure 62. World Genome Editing Enzymes Production Value Market Share by Application (2021-2032)
Figure 63. World Genome Editing Enzymes Average Price by Application (2021-2032) & (US$/µg)
Figure 64. Genome Editing Enzymes Industry Chain
Figure 65. Genome Editing Enzymes Procurement Model
Figure 66. Genome Editing Enzymes Sales Model
Figure 67. Genome Editing Enzymes Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
Figure 1. Genome Editing Enzymes Picture
Figure 2. World Genome Editing Enzymes Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Genome Editing Enzymes Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Genome Editing Enzymes Production (2021-2032) & (µg)
Figure 5. World Genome Editing Enzymes Average Price (2021-2032) & (US$/µg)
Figure 6. World Genome Editing Enzymes Production Value Market Share by Region (2021-2032)
Figure 7. World Genome Editing Enzymes Production Market Share by Region (2021-2032)
Figure 8. North America Genome Editing Enzymes Production (2021-2032) & (µg)
Figure 9. Europe Genome Editing Enzymes Production (2021-2032) & (µg)
Figure 10. China Genome Editing Enzymes Production (2021-2032) & (µg)
Figure 11. Japan Genome Editing Enzymes Production (2021-2032) & (µg)
Figure 12. Genome Editing Enzymes Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Genome Editing Enzymes Consumption (2021-2032) & (µg)
Figure 15. World Genome Editing Enzymes Consumption Market Share by Region (2021-2032)
Figure 16. United States Genome Editing Enzymes Consumption (2021-2032) & (µg)
Figure 17. China Genome Editing Enzymes Consumption (2021-2032) & (µg)
Figure 18. Europe Genome Editing Enzymes Consumption (2021-2032) & (µg)
Figure 19. Japan Genome Editing Enzymes Consumption (2021-2032) & (µg)
Figure 20. South Korea Genome Editing Enzymes Consumption (2021-2032) & (µg)
Figure 21. ASEAN Genome Editing Enzymes Consumption (2021-2032) & (µg)
Figure 22. India Genome Editing Enzymes Consumption (2021-2032) & (µg)
Figure 23. Producer Shipments of Genome Editing Enzymes by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Genome Editing Enzymes Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Genome Editing Enzymes Markets in 2025
Figure 26. United States VS China: Genome Editing Enzymes Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Genome Editing Enzymes Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Genome Editing Enzymes Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Genome Editing Enzymes Production Market Share 2025
Figure 30. China Based Manufacturers Genome Editing Enzymes Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Genome Editing Enzymes Production Market Share 2025
Figure 32. World Genome Editing Enzymes Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Genome Editing Enzymes Production Value Market Share by Type in 2025
Figure 34. CRISPR-Associated (Cas) Enzymes
Figure 35. Base Editing Enzymes
Figure 36. Prime Editors
Figure 37. Others
Figure 38. World Genome Editing Enzymes Production Market Share by Type (2021-2032)
Figure 39. World Genome Editing Enzymes Production Value Market Share by Type (2021-2032)
Figure 40. World Genome Editing Enzymes Average Price by Type (2021-2032) & (US$/µg)
Figure 41. World Genome Editing Enzymes Production Value by State, (USD Million), 2021 & 2025 & 2032
Figure 42. World Genome Editing Enzymes Production Value Market Share by State in 2025
Figure 43. Wild-Type Cleaving Nucleases
Figure 44. PAM-Engineered Nucleases
Figure 45. World Genome Editing Enzymes Production Market Share by State (2021-2032)
Figure 46. World Genome Editing Enzymes Production Value Market Share by State (2021-2032)
Figure 47. World Genome Editing Enzymes Average Price by State (2021-2032) & (US$/µg)
Figure 48. World Genome Editing Enzymes Production Value by Quality, (USD Million), 2021 & 2025 & 2032
Figure 49. World Genome Editing Enzymes Production Value Market Share by Quality in 2025
Figure 50. Research Use Grade
Figure 51. Process-Development Grade
Figure 52. World Genome Editing Enzymes Production Market Share by Quality (2021-2032)
Figure 53. World Genome Editing Enzymes Production Value Market Share by Quality (2021-2032)
Figure 54. World Genome Editing Enzymes Average Price by Quality (2021-2032) & (US$/µg)
Figure 55. World Genome Editing Enzymes Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Genome Editing Enzymes Production Value Market Share by Application in 2025
Figure 57. Basic Research
Figure 58. Biomedicine
Figure 59. Agriculture
Figure 60. Others
Figure 61. World Genome Editing Enzymes Production Market Share by Application (2021-2032)
Figure 62. World Genome Editing Enzymes Production Value Market Share by Application (2021-2032)
Figure 63. World Genome Editing Enzymes Average Price by Application (2021-2032) & (US$/µg)
Figure 64. Genome Editing Enzymes Industry Chain
Figure 65. Genome Editing Enzymes Procurement Model
Figure 66. Genome Editing Enzymes Sales Model
Figure 67. Genome Editing Enzymes Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
